Showing results (31-40 of 306) with videos related to
Sort By:
Pageof 31
Expert Opinion on Drug Discovery|March 15, 2013
Designing a ligand for pharmaceutical purposesAndrea Bortolato, Stefano MoroMolecules (Basel, Switzerland)|July 14, 2023
Correction: Bassani, D.; Moro, S. Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies. Molecules 2023, 28, 3906Davide Bassani, Stefano MoroCurrent Drug Discovery Technologies|February 22, 2007
Ligand-based drug design methodologies in drug discovery process: an overviewMagdalena Bacilieri, Stefano MoroFrontiers in Pharmacology|September 7, 2018
Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An OverviewVeronica Salmaso, Stefano MoroJournal of Chemical Information and Modeling|January 25, 2014
Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scaleDavide Sabbadin, Stefano MoroMarine Drugs|May 26, 2023
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal AdenocarcinomaDaniela Carbone, Michele De Franco, Camilla Pecoraro, et al.Current Pharmaceutical Design|October 9, 2002
Molecular modeling as a tool to investigate molecular recognition in P2Y receptorsStefano Moro, Kenneth A JacobsonEuropean Journal of Medicinal Chemistry|December 10, 2022
Streptogramin A derivatives as mitochondrial translation inhibitors to suppress glioblastoma stem cell growthDenise Sighel, Giulia Battistini, Emanuele Filiberto Rosatti, et al.Anti-Cancer Agents in Medicinal Chemistry|October 16, 2008
Protein kinase CK2 inhibitors: emerging anticancer therapeutic agents?Andrea Bortolato, Giorgio Cozza, Stefano MoroDrug Discovery Today|June 28, 2020
The rise of molecular simulations in fragment-based drug design (FBDD): an overviewMaicol Bissaro, Mattia Sturlese, Stefano MoroPageof 31